A history of glaucoma pharmacology

Optometry and Vision Science

Volumn 88, Issue 1, 2011, Pages 36-38

  Realini, Tony ^a  

^a West Virginia University Eye Institute   (United States)

Author keywords

Glaucoma; history; pharmacology

Indexed keywords

20TH CENTURY; BETA-BLOCKERS; CALABAR; DRUG DISCOVERY; GLAUCOMA; INTRA OCULAR PRESSURE; PHARMACOLOGY;

CARBONIC ANHYDRASE;

OPHTHALMOLOGY;

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; MIOTIC AGENT; PROSTAGLANDIN;

DRUG EFFECT; GLAUCOMA; HISTORY; HUMAN; INTRAOCULAR PRESSURE; PATHOPHYSIOLOGY; REVIEW;

ADRENERGIC AGONISTS; ADRENERGIC BETA-ANTAGONISTS; CARBONIC ANHYDRASE INHIBITORS; GLAUCOMA; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; INTRAOCULAR PRESSURE; MIOTICS; PROSTAGLANDINS;

EID: 78651500694     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3182058ead     Document Type: Review

References (10)

1. Kronfeld PC. Glaucoma. In: Albert DM, Edwards DD, eds. The History of Ophthalmology. Cambridge, MA: Blackwell Science; 1996:203-23.
2. Krupen T. Autonomie drugs: controlling the inflow. In: van Buskirk EM, Shields MB, eds. 100 Years of Progress in Glaucoma. Philadelphia, PA: Lippincott-Raven; 1997:262-71.
3. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. Am J Ophthalmol 1954;37:13-5.
4. Zimmerman TJ. Carbonic anhydrase inhibitors: from pills to drops. In: van Buskirk EM, Shields MB, eds. 100 Years of Progress in Glaucoma. Philadelphia, PA: Lippincott-Raven; 1997:272-7.
5. Zimmerman TJ, Kaufman HE. Timolol, dose response and duration of action. Arch Ophthalmol 1977;95:605-7.
6. Katz IM, Hubbard WA, Getson AJ, Gould AL. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol 1976;15:489-92.
7. Camras CB, Bito LZ, Toris CB. Prostaglandins and prostaglandin analogues. In: Zimmerman TJ, Kooner KS, Sharir M, Fechtner RD, eds. Textbook of Ocular Pharmacology. Philadelphia, PA: Lippincott-Raven; 1997:315-28.
8. Camras CB, Bito LZ. Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha. Curr Eye Res 1981;1:205-9.
9. Xalatan Patent Affirmed by Appeals Court. FDAnews Drug Daily Bulletin [serial online]. August 23, 2005; volume 2, number 165. Available at: http://www.fdanews.com/newsletter/article?articleId=75604&issueId=7953. Accessed October 28, 2010.
10. Jampel HD, Bacharach J, Sheu WP, Wohl LG, Solish AM, Christie W. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure. Am J Ophthalmol 2002; 134:863-71.